A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours

Clinical trial NCT01721148 · COMPLETED

Trial details

NCT number: NCT01721148
Sponsor: ASLAN Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumour

Start date: 2012-10-01
Primary completion: 2016-12-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.